
A survey finds that delay-related harm fell sharply. Strong trust in AI also collapsed, and clinicians now want strict limits and human oversight.
The numbers behind the University of Mississippi's cardiometabolic disorders program
The following data were evaluated to determine the University of Mississippi's standing as a Clinical Center of Excellence for cardiometabolic disorders:
2007: Year founded
8: Faculty
8: Research protocols annually
6: Annual faculty publications
75 percent: Patients reaching target LDL levels
50 percent: Patients reaching all target lipid levels
1.5 percent: Average HbA1C reduction
90 percent: Achievement of quality assurance treatment markers such as annual monofilament foot examinations, aspirin therapy, and vaccinations




